Literature DB >> 22105257

Five-year follow-up after comparing bipolar endometrial ablation with hydrothermablation for menorrhagia.

Josien P M Penninx1, Malou C Herman, Ben W Mol, Marlies Y Bongers.   

Abstract

OBJECTIVE: To evaluate the results of a previous study comparing bipolar radiofrequency endometrial ablation with hydrothermablation for the treatment of menorrhagia at 5-year follow-up.
METHOD: A double-blind, randomized, controlled trial was performed in a large teaching hospital in the Netherlands between March 2005 and August 2007. One-hundred sixty women with menorrhagia were randomly allocated to bipolar ablation or hydrothermablation. The results of follow-up at 12 months were previously reported. At 4-5 years of follow-up, a questionnaire was sent to all the participants to register amenorrhea rates, reinterventions, and patient satisfaction.
RESULTS: At 5-year follow-up, response rates were 90% and 83% in the bipolar group and hydrotherm group, respectively. Amenorrhea rates were 55.4% and 35.3% in the bipolar group and the hydrotherm group, respectively (relative risk [RR] 1.5, 95% confidence interval [CI] 1.05-2.3). The number of surgical reinterventions was 11 compared with 23 (RR 0.43, 95% CI 0.23-0.80). Overall, more women were satisfied in the bipolar group compared with the hydrotherm group.
CONCLUSION: After treatment, bipolar radiofrequency endometrial ablation system is more effective at 5 years than hydrothermablation in the treatment of menorrhagia. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2011        PMID: 22105257     DOI: 10.1097/AOG.0b013e318236f7ed

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Incidence and predictors of failed second-generation endometrial ablation.

Authors:  Jordan Klebanoff; Gretchen E Makai; Nima R Patel; Matthew K Hoffman
Journal:  Gynecol Surg       Date:  2017-12-15

2.  Endometrial resection and ablation techniques for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Mihaela Grigore; Julie Brown; Martha Hickey; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2019-01-22

3.  Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial.

Authors:  Malou C Herman; Marian J van den Brink; Peggy M Geomini; Hannah S van Meurs; Judith A Huirne; Heleen P Eising; Anne Timmermans; Johanna M A Pijnenborg; Ellen R Klinkert; Sjors F Coppus; Theodoor E Nieboer; Ruby Catshoek; Lucet F van der Voet; Hugo W F van Eijndhoven; Giuseppe C M Graziosi; Sebastiaan Veersema; Paul J van Kesteren; Josje Langenveld; Nicol A C Smeets; Huib A A M van Vliet; Jan Willem van der Steeg; Yvonne Lisman-van Leeuwen; Janny H Dekker; Ben W Mol; Marjolein Y Berger; Marlies Y Bongers
Journal:  BMC Womens Health       Date:  2013-08-08       Impact factor: 2.809

Review 4.  Ten-year literature review of global endometrial ablation with the NovaSure® device.

Authors:  Richard J Gimpelson
Journal:  Int J Womens Health       Date:  2014-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.